|
The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
Avenue Capital Group Provides $18MM Growth Capital Facility to Epica International
Friday, September 20, 2024
|
Lenders/Participants
|
Avenue Capital [Lender]
|
|
Structure
|
Growth Capital Facility
|
|
Amount
|
$18.000
Million
|
|
Borrower(s)
|
Epica International Inc.
|
|
Description
|
The initial funding of $13.5 million will be used to refinance existing debt, support strategic expansion, and accelerate research and development initiatives. An additional $4.5 million is available in tranches upon the achievement of specific performance milestones. The growth capital loan has a four-year term and includes provisions for Avenue Capital to receive a 0.5% equity stake in Epica International, with an option to invest an additional $2 million in equity within two years. The lender also has the right to convert up to $3.5 million of their principal into common stock at a price of $8.50 per share.
|
|
Industry
|
Medical
|
|
Location
|
SC
|
| Related Tags |
Avenue Capital Group
|
ABL Advisor
Deal Tables
2025
|
|
|
|